Income Statement Nectar Lifesciences Limited

Stocks

NECLIFE

INE023H01027

Pharmaceuticals

Market Closed - NSE India S.E. 08:11:05 2026-08-14 EDT			5-day change	1st Jan Change
11.00 ^INR	-3.00%		+3.97%	-43.33%

08-14	Nectar Lifesciences Limited Announces Board and Committee Changes, Effective August 14, 2026	CI
08-14	Nectar Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

83119.ZOGWgmYR3FLS8NPOfmVQjFMVzD4fJb-dUeltFugGd7A.BbfY-A97jDCemKWRFwoZzzZA_XdOZtL1P9EZWcVxI-Iyt9PjVUaTJpCZhg

Published financial data: NECTAR LIFESCIENCES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	15.43B	16.69B	15.24B	16.84B	16.7B
Other Revenues, Total	250K	250K	240K	4.85M	3.92M
Total Revenues	15.43B	16.69B	15.24B	16.85B	16.7B
Cost of Goods Sold, Total	11.57B	12.23B	11.59B	12.02B	13.88B
Gross Profit	3.86B	4.46B	3.64B	4.82B	2.82B
Selling General & Admin Expenses, Total	752M	763M	796M	866M	985M
Provision for Bad Debts	120M	-	-	-	-
Depreciation & Amortization - (IS)	602M	570M	591M	607M	624M
Other Operating Expenses	1.89B	2.11B	2.31B	2.42B	2.09B
Other Operating Expenses, Total	3.36B	3.44B	3.7B	3.89B	3.7B
Operating Income	500M	1.02B	-51.73M	928M	-885M
Interest Expense, Total	-858M	-699M	-828M	-896M	-771M
Interest And Investment Income	26.82M	18.84M	17.26M	124M	14.89M
Net Interest Expenses	-831M	-681M	-811M	-772M	-756M
Currency Exchange Gains (Loss)	-84.92M	4.68M	98.78M	97.5M	385M
Other Non Operating Income (Expenses)	-178M	-93.34M	-65.66M	-72.69M	-361M
EBT, Excl. Unusual Items	-594M	247M	-829M	181M	-1.62B
Gain (Loss) On Sale Of Investments	400K	30K	1.05M	1.8M	350K
Gain (Loss) On Sale Of Assets	-1.31M	94.07M	404M	-	-140K
Other Unusual Items	-253M	-	-	-	-
EBT, Incl. Unusual Items	-848M	341M	-424M	183M	-1.62B
Income Tax Expense	-115M	90.34M	-182M	133M	-479M
Earnings From Continuing Operations	-733M	250M	-242M	49.95M	-1.14B
Net Income to Company	-733M	250M	-242M	49.95M	-1.14B
Net Income - (IS)	-733M	250M	-242M	49.95M	-1.14B
Net Income to Common Incl Extra Items	-733M	250M	-242M	49.95M	-1.14B
Net Income to Common Excl. Extra Items	-733M	250M	-242M	49.95M	-1.14B
Per Share Items
Net EPS - Basic	-3.27	1.12	-1.08	0.22	-5.07
Basic EPS - Continuing Operations	-3.27	1.12	-1.08	0.22	-5.07
Basic Weighted Average Shares Outstanding	224M	224M	224M	224M	224M
Net EPS - Diluted	-3.27	1.12	-1.08	0.22	-5.07
Diluted EPS - Continuing Operations	-3.27	1.12	-1.08	0.22	-5.07
Diluted Weighted Average Shares Outstanding	224M	224M	224M	224M	224M
Normalized Basic EPS	-1.65	0.69	-2.31	0.5	-4.5
Normalized Diluted EPS	-1.65	0.69	-2.31	0.5	-4.5
Dividend Per Share	-	-	-	-	-
Payout Ratio	-1.53	-	-	-	-
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	1.1B	1.59B	539M	1.54B	-261M
EBITA	619M	1.09B	38.37M	1.04B	-764M
EBIT	500M	1.02B	-51.73M	928M	-885M
EBITDAR	1.12B	1.6B	558M	1.55B	-240M
Total Revenues (As Reported)	15.47B	16.8B	15.67B	16.99B	16.75B
Effective Tax Rate - (Ratio)	13.57	26.51	42.99	72.66	29.62
Total Current Taxes	85.86M	-	68.93M	64.15M	79.05M
Total Deferred Taxes	-201M	90.34M	-251M	68.59M	-558M
Normalized Net Income	-371M	154M	-518M	113M	-1.01B
Non-Cash Pension Expense	6.57M	6.39M	6.05M	8.06M	9.56M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	24.35M	30.7M	26.54M	67.06M	85.51M
Net Rental Expense, Total	17.81M	17.64M	18.3M	18.93M	20.35M
Imputed Operating Lease Interest Expense	14.53M	11.2M	15.02M	19.54M	20.61M
Imputed Operating Lease Depreciation	3.28M	6.44M	3.28M	-608K	-256K
Maintenance & Repair Expenses, Total	-	-	-	-	205M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	255M	178M	176M	198M	192M
Short Term Investments	4.57M	4.6M	-	-	-
Trading Asset Securities, Total	-	-	3.14M	4.95M	5.3M
Total Cash And Short Term Investments	260M	183M	179M	203M	198M
Accounts Receivable, Total	3.75B	4.47B	2.8B	3.79B	3.45B
Other Receivables	464M	671M	638M	423M	460M
Notes Receivable	4.29M	3.94M	3.73M	9.24M	8.57M
Total Receivables	4.22B	5.14B	3.44B	4.22B	3.92B
Inventory	6.55B	7.21B	7.32B	7.77B	7.42B
Other Current Assets, Total	1.36B	1.01B	1.38B	646M	832M
Total Current Assets	12.39B	13.55B	12.31B	12.84B	12.38B
Gross Property Plant And Equipment	15B	14.81B	14.54B	14.69B	14.96B
Accumulated Depreciation	-6.68B	-7.16B	-7.63B	-8.13B	-8.63B
Net Property Plant And Equipment	8.32B	7.65B	6.9B	6.56B	6.33B
Long-term Investments	2.35M	2.35M	2.35M	2.35M	2.35M
Other Intangibles, Total	384M	430M	493M	524M	565M
Accounts Receivable Long-Term	103M	78.28M	73.46M	81.54M	84.87M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	-	28M	206M	74.78M	550M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	3.51B	2.17B	1.9B	1.83B	560M
Total Assets	24.71B	23.91B	21.89B	21.91B	20.47B
Liabilities
Accounts Payable, Total	3.42B	3.77B	3.19B	4.2B	4.38B
Accrued Expenses, Total	144M	120M	383M	154M	151M
Short-term Borrowings	7.12B	5.03B	4.59B	4.12B	4.4B
Current Portion of Long-Term Debt	632M	661M	684M	830M	817M
Current Income Taxes Payable	-	-	-	-	-
Other Current Liabilities	557M	463M	65.26M	426M	464M
Total Current Liabilities	11.87B	10.04B	8.91B	9.73B	10.22B
Long-Term Debt	1.28B	2.91B	2.26B	1.4B	601M
Unearned Revenue Non Current	8.21M	7.96M	7.71M	7.46M	7.21M
Pension & Other Post Retirement Benefits	77.38M	63.93M	64.46M	79.37M	87.28M
Deferred Tax Liability Non Current	830M	-	-	-	-
Other Non Current Liabilities	18.95M	8.3M	-	-10K	10K
Total Liabilities	14.09B	13.03B	11.25B	11.22B	10.91B
Common Stock, Total	224M	224M	224M	224M	224M
Additional Paid In Capital	3.29B	3.29B	3.29B	3.29B	3.29B
Retained Earnings	7.11B	7.37B	7.13B	7.18B	6.05B
Comprehensive Income and Other	-	-	10K	-	-
Total Common Equity	10.62B	10.88B	10.65B	10.69B	9.56B
Total Equity	10.62B	10.88B	10.65B	10.69B	9.56B
Total Liabilities And Equity	24.71B	23.91B	21.89B	21.91B	20.47B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	224M	224M	224M	224M	224M
ECS Total Common Shares Outstanding	224M	224M	224M	224M	224M
Book Value / Share	47.36	48.51	47.47	47.68	42.63
Tangible Book Value	10.24B	10.45B	10.15B	10.17B	9B
Tangible Book Value Per Share	45.65	46.59	45.27	45.34	40.11
Total Debt	9.03B	8.6B	7.54B	6.36B	5.82B
Net Debt	8.77B	8.42B	7.36B	6.15B	5.62B
Debt Equivalent of Unfunded Proj. Benefit Obligation	93.48M	80.91M	83.06M	102M	116M
Debt Equivalent Oper. Leases	142M	141M	146M	151M	163M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	1.14B	1.58B	1.2B	1.1B	820M
Inventories - Work In Process, Total	2.98B	3.71B	5.16B	5.39B	5.72B
Inventories - Finished Goods, Total	1.63B	1.13B	207M	458M	229M
Inventories - Others	130M	175M	160M	142M	135M
Land - (BS)	806M	516M	192M	192M	192M
Buildings, Total	1.75B	1.77B	1.76B	1.8B	1.82B
Machinery, Total	9.75B	9.94B	10.01B	10.19B	10.45B
Full Time Employees	1.69K	1.67K	1.59K	1.69K	1.79K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-733M	250M	-242M	49.95M	-1.14B
Depreciation & Amortization - CF	483M	491M	501M	494M	503M
Amortization of Goodwill and Intangible Assets - (CF)	119M	78.95M	90.1M	113M	121M
Depreciation & Amortization, Total	603M	570M	591M	607M	624M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	1.31M	-94.07M	-404M	-	140K
(Gain) Loss on Sale of Investments - (CF)	-400K	-30K	-1.05M	-1.8M	-350K
Provision and Write-off of Bad Debts	-54.75M	9.65M	2.23M	9.33M	16.08M
Other Operating Activities, Total	803M	860M	611M	894M	272M
Change in Other Net Operating Assets	-405M	-645M	779M	689M	1.92B
Cash from Operations	214M	950M	1.34B	2.25B	1.69B
Capital Expenditure	-312M	-250M	-301M	-294M	-438M
Sale of Property, Plant, and Equipment	1.85M	397M	798M	-	80K
Investment in Marketable and Equity Securities, Total	-2.5M	-	2.5M	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	26.82M	18.83M	17.26M	124M	18.57M
Cash from Investing	-286M	166M	517M	-170M	-419M
Short Term Debt Issued, Total	923M	-	-	-	280M
Long-Term Debt Issued, Total	331M	1.57B	10K	4.12M	-
Total Debt Issued	1.25B	1.57B	10K	4.12M	280M
Short Term Debt Repaid, Total	-	-2.06B	-439M	-467M	-
Long-Term Debt Repaid, Total	-7.28M	-10.28M	-652M	-720M	-815M
Total Debt Repaid	-7.28M	-2.07B	-1.09B	-1.19B	-815M
Common Dividends Paid	-11.21M	-	-	-	-
Common & Preferred Stock Dividends Paid	-11.21M	-	-	-	-
Other Financing Activities, Total	-1.12B	-688M	-765M	-871M	-746M
Cash from Financing	115M	-1.19B	-1.86B	-2.05B	-1.28B
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	42.45M	-77.31M	-2.28M	22.26M	-5.84M
Supplemental Items
Cash Interest Paid	1.12B	788M	795M	871M	746M
Cash Income Tax Paid (Refund)	37.13M	-	-	-	-
Levered Free Cash Flow	2.09B	-492M	260M	971M	-171M
Unlevered Free Cash Flow	2.63B	-54.91M	777M	1.53B	311M
Change In Net Working Capital	-2.02B	1.01B	-519M	-638M	-678M
Net Debt Issued / Repaid	1.25B	-506M	-1.09B	-1.18B	-535M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.22	2.66	-0.14	2.65	-2.61
Return on Total Capital	1.61	3.25	-0.17	3.29	-3.41
Return On Equity %	-6.67	2.33	-2.25	0.47	-11.23
Return on Common Equity	-6.67	2.33	-2.25	0.47	-11.23
Margin Analysis
Gross Profit Margin %	25.02	26.71	23.92	28.63	16.88
SG&A Margin	4.87	4.57	5.22	5.14	5.9
EBITDA Margin %	7.14	9.5	3.54	9.12	-1.56
EBITA Margin %	4.01	6.56	0.25	6.18	-4.57
EBIT Margin %	3.24	6.09	-0.34	5.51	-5.3
Income From Continuing Operations Margin %	-4.75	1.5	-1.59	0.3	-6.81
Net Income Margin %	-4.75	1.5	-1.59	0.3	-6.81
Net Avail. For Common Margin %	-4.75	1.5	-1.59	0.3	-6.81
Normalized Net Income Margin	-2.4	0.92	-3.4	0.67	-6.04
Levered Free Cash Flow Margin	13.55	-2.95	1.7	5.76	-1.02
Unlevered Free Cash Flow Margin	17.02	-0.33	5.1	9.09	1.86
Asset Turnover
Asset Turnover	0.6	0.7	0.67	0.77	0.79
Fixed Assets Turnover	1.82	2.09	2.09	2.5	2.59
Receivables Turnover (Average Receivables)	4	4.06	4.19	5.11	4.61
Inventory Turnover (Average Inventory)	1.39	1.78	1.6	1.59	1.83
Short Term Liquidity
Current Ratio	1.04	1.35	1.38	1.32	1.21
Quick Ratio	0.38	0.53	0.41	0.45	0.4
Operating Cash Flow to Current Liabilities	0.02	0.09	0.15	0.23	0.17
Days Sales Outstanding (Average Receivables)	91.14	89.87	87.03	71.59	79.2
Days Outstanding Inventory (Average Inventory)	262.35	205.4	228.7	229.55	199.63
Average Days Payable Outstanding	197.24	101.76	108.51	108.34	115.6
Cash Conversion Cycle (Average Days)	156.25	193.5	207.22	192.79	163.23
Long Term Solvency
Total Debt/Equity	85.06	79.04	70.81	59.44	60.87
Total Debt / Total Capital	45.96	44.15	41.46	37.28	37.84
LT Debt/Equity	12.07	26.76	21.27	13.12	6.29
Long-Term Debt / Total Capital	6.52	14.94	12.45	8.23	3.91
Total Liabilities / Total Assets	57.02	54.5	51.37	51.2	53.3
EBIT / Interest Expense	0.58	1.45	-0.06	1.04	-1.15
EBITDA / Interest Expense	1.29	2.27	0.65	1.71	-0.34
(EBITDA - Capex) / Interest Expense	0.92	1.91	0.29	1.39	-0.91
Total Debt / EBITDA	8.19	5.42	13.97	4.14	-22.32
Net Debt / EBITDA	7.96	5.31	13.64	4.01	-21.56
Total Debt / (EBITDA - Capex)	11.44	6.44	31.56	5.12	-8.33
Net Debt / (EBITDA - Capex)	11.11	6.3	30.81	4.96	-8.05
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-34.78	8.13	-8.7	10.56	-0.84
Gross Profit, 1 Yr. Growth %	-23.94	15.41	-18.24	32.36	-39.38
EBITDA, 1 Yr. Growth %	-49.91	43.83	-65.98	184.65	-116.98
EBITA, 1 Yr. Growth %	-64.12	76.79	-96.5	2.61K	-173.33
EBIT, 1 Yr. Growth %	-68.62	103.23	-105.09	-1.9K	-195.29
Earnings From Cont. Operations, 1 Yr. Growth %	-330.47	-134.19	-196.55	-120.66	-2.38K
Net Income, 1 Yr. Growth %	-330.47	-134.19	-196.55	-120.66	-2.38K
Normalized Net Income, 1 Yr. Growth %	-259.64	-141.56	-436.16	-121.81	-993.11
Diluted EPS Before Extra, 1 Yr. Growth %	-330.69	-134.15	-196.7	-120.37	-2.4K
Accounts Receivable, 1 Yr. Growth %	-5.32	19.25	-37.45	35.62	-8.89
Inventory, 1 Yr. Growth %	-34.99	10.06	1.42	6.15	-4.41
Net Property, Plant and Equip., 1 Yr. Growth %	-3.31	-8.05	-9.77	-4.98	-3.46
Total Assets, 1 Yr. Growth %	-6.16	0.11	-8.43	0.08	-6.56
Tangible Book Value, 1 Yr. Growth %	-6.68	2.07	-2.83	0.16	-11.53
Common Equity, 1 Yr. Growth %	-6.52	2.44	-2.14	0.44	-10.58
Cash From Operations, 1 Yr. Growth %	-92.5	344.38	40.68	68.11	-24.59
Capital Expenditures, 1 Yr. Growth %	-42.96	-20.07	20.38	-2.15	48.89
Levered Free Cash Flow, 1 Yr. Growth %	60.54	-123.53	-152.75	274.05	-117.61
Unlevered Free Cash Flow, 1 Yr. Growth %	40.02	-102.09	-1.52K	97.03	-79.72
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-25.53	-16.02	-0.64	0.47	4.7
Gross Profit, 2 Yr. CAGR %	-17.34	-6.31	-2.86	4.02	-12.05
EBITDA, 2 Yr. CAGR %	-35.44	-15.12	-30.05	-1.59	-30.47
EBITA, 2 Yr. CAGR %	-46.59	-20.35	-75.11	-2.48	346.03
EBIT, 2 Yr. CAGR %	-50.16	-20.15	-67.83	-4.41	313.58
Earnings From Cont. Operations, 2 Yr. CAGR %	24.06	-11.24	-42.55	-55.34	116.81
Net Income, 2 Yr. CAGR %	24.06	-11.24	-42.55	-55.34	116.81
Normalized Net Income, 2 Yr. CAGR %	0.27	-18.55	18.2	-14.37	39.57
Diluted EPS Before Extra, 2 Yr. CAGR %	24.2	-11.24	-42.53	-55.62	116.67
Accounts Receivable, 2 Yr. CAGR %	-18.09	6.26	-13.63	-7.89	11.16
Inventory, 2 Yr. CAGR %	-15.51	-15.41	5.65	3.76	0.73
Net Property, Plant and Equip., 2 Yr. CAGR %	-3.04	-5.71	-8.91	-7.4	-4.22
Total Assets, 2 Yr. CAGR %	-4.42	-4.72	-4.26	-4.27	-3.3
Tangible Book Value, 2 Yr. CAGR %	-2	-2.4	-0.41	-1.35	-5.87
Common Equity, 2 Yr. CAGR %	-1.97	-2.15	0.12	-0.86	-5.23
Cash From Operations, 2 Yr. CAGR %	-70.11	-42.26	150.03	53.79	12.6
Capital Expenditures, 2 Yr. CAGR %	-9.48	-32.48	-1.91	8.54	20.7
Levered Free Cash Flow, 2 Yr. CAGR %	54.78	-38.54	-64.77	40.47	-18.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	35.93	-82.89	-45.62	428.05	-36.78
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-6.3	-15.67	-13.65	2.96	0.03
Gross Profit, 3 Yr. CAGR %	-8.81	-7.61	-10.47	7.69	-14.16
EBITDA, 3 Yr. CAGR %	-22.48	-15.68	-37.42	11.68	-45.21
EBITA, 3 Yr. CAGR %	-31.16	-20.4	-71.88	18.91	-11.32
EBIT, 3 Yr. CAGR %	-33.8	-20.37	-68.1	22.92	-4.51
Earnings From Cont. Operations, 3 Yr. CAGR %	11.91	-19.27	-8.71	-59.15	65.57
Net Income, 3 Yr. CAGR %	11.91	-19.27	-8.71	-59.15	65.57
Normalized Net Income, 3 Yr. CAGR %	-1.62	-25.24	30.65	-32.71	87.09
Diluted EPS Before Extra, 3 Yr. CAGR %	11.96	-19.24	-8.67	-59.33	65.58
Accounts Receivable, 3 Yr. CAGR %	-15.08	-7.17	-10.94	0.39	-8.23
Inventory, 3 Yr. CAGR %	-8.64	-7.72	-10.14	5.82	0.96
Net Property, Plant and Equip., 3 Yr. CAGR %	-2.8	-4.74	-7.08	-7.62	-6.11
Total Assets, 3 Yr. CAGR %	-3.19	-4.03	-5.97	-2.83	-5.04
Tangible Book Value, 3 Yr. CAGR %	0.36	-0.66	-2.55	-0.22	-4.87
Common Equity, 3 Yr. CAGR %	0.11	-0.52	-2.14	0.23	-4.21
Cash From Operations, 3 Yr. CAGR %	-31.03	-26.5	-22.3	119.04	21.27
Capital Expenditures, 3 Yr. CAGR %	-1.97	-13.16	-18.12	-1.99	20.6
Levered Free Cash Flow, 3 Yr. CAGR %	40.81	-17.39	-41.59	-22.57	-29.69
Unlevered Free Cash Flow, 3 Yr. CAGR %	137.22	-66.2	-25.46	-16.47	78.17
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.63	0.3	-4.08	-9.55	-6.73
Gross Profit, 5 Yr. CAGR %	-5.1	-1.85	-6.47	-3.12	-11.1
EBITDA, 5 Yr. CAGR %	-14.34	-6.73	-25.6	-10.3	-34.73
EBITA, 5 Yr. CAGR %	-20.72	-9.34	-54.17	-13.67	-15.05
EBIT, 5 Yr. CAGR %	-22.74	-8.96	-50.4	-14.33	-11.1
Earnings From Cont. Operations, 5 Yr. CAGR %	6.2	-14.66	-14.29	-36.29	29.03
Net Income, 5 Yr. CAGR %	6.2	-14.66	-14.29	-36.29	29.03
Normalized Net Income, 5 Yr. CAGR %	-1.49	-13.8	5.88	-21.07	34.15
Diluted EPS Before Extra, 5 Yr. CAGR %	6.22	-14.66	-14.25	-36.44	29.03
Accounts Receivable, 5 Yr. CAGR %	-5.27	-2.21	-14.5	-7.46	-2.69
Inventory, 5 Yr. CAGR %	-4.77	-3.34	-3.17	-3.29	-5.94
Net Property, Plant and Equip., 5 Yr. CAGR %	-2.34	-3.74	-5.29	-5.81	-5.95
Total Assets, 5 Yr. CAGR %	-0.68	-1.52	-4.28	-4.13	-4.91
Tangible Book Value, 5 Yr. CAGR %	2.93	1.94	0.05	-0.94	-3.89
Common Equity, 5 Yr. CAGR %	2.17	1.56	0.11	-0.66	-3.39
Cash From Operations, 5 Yr. CAGR %	-33.85	-13.72	15.45	-1.25	-9.88
Capital Expenditures, 5 Yr. CAGR %	-17.62	-14.1	-1.95	-5.06	-4.37
Levered Free Cash Flow, 5 Yr. CAGR %	46.53	5.43	-19.1	2.15	-33.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	62.19	-43.63	31.61	1.49	-30.21
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	-